全文获取类型
收费全文 | 434233篇 |
免费 | 36986篇 |
国内免费 | 13111篇 |
专业分类
耳鼻咽喉 | 2908篇 |
儿科学 | 8926篇 |
妇产科学 | 7275篇 |
基础医学 | 69847篇 |
口腔科学 | 8526篇 |
临床医学 | 28437篇 |
内科学 | 66262篇 |
皮肤病学 | 6516篇 |
神经病学 | 38611篇 |
特种医学 | 12140篇 |
外国民族医学 | 75篇 |
外科学 | 35544篇 |
综合类 | 53808篇 |
现状与发展 | 55篇 |
一般理论 | 8篇 |
预防医学 | 25077篇 |
眼科学 | 5175篇 |
药学 | 58114篇 |
98篇 | |
中国医学 | 19668篇 |
肿瘤学 | 37260篇 |
出版年
2023年 | 5685篇 |
2022年 | 7723篇 |
2021年 | 16016篇 |
2020年 | 14534篇 |
2019年 | 16270篇 |
2018年 | 16034篇 |
2017年 | 15957篇 |
2016年 | 15496篇 |
2015年 | 16759篇 |
2014年 | 22297篇 |
2013年 | 28475篇 |
2012年 | 23652篇 |
2011年 | 27917篇 |
2010年 | 21562篇 |
2009年 | 21429篇 |
2008年 | 22414篇 |
2007年 | 21954篇 |
2006年 | 20279篇 |
2005年 | 17712篇 |
2004年 | 15534篇 |
2003年 | 13638篇 |
2002年 | 10706篇 |
2001年 | 9481篇 |
2000年 | 8011篇 |
1999年 | 6797篇 |
1998年 | 5401篇 |
1997年 | 5319篇 |
1996年 | 4634篇 |
1995年 | 4463篇 |
1994年 | 4171篇 |
1993年 | 3480篇 |
1992年 | 2976篇 |
1991年 | 2797篇 |
1990年 | 2337篇 |
1989年 | 1961篇 |
1988年 | 1760篇 |
1987年 | 1556篇 |
1986年 | 1556篇 |
1985年 | 3279篇 |
1984年 | 3765篇 |
1983年 | 2515篇 |
1982年 | 2781篇 |
1981年 | 2442篇 |
1980年 | 2078篇 |
1979年 | 1740篇 |
1978年 | 1369篇 |
1977年 | 1165篇 |
1976年 | 1229篇 |
1975年 | 874篇 |
1974年 | 729篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
《Clinical breast cancer》2022,22(6):507-514
Breast cancer (BC) is a highly metastatic, pathological cancer that significantly affects women worldwide. The mortality rate of BC is related to its heterogeneity, aggressive phenotype, and metastasis. Recent studies have highlighted that the tumor microenvironment (TME) is critical for the interplay between metastasis mediators in BC. BC stem cells, tumor-derived exosomes, circulatory tumor cells (CTCs), and signaling pathways dynamically remodel the TME and promote metastasis. This review examines the cellular and molecular mechanisms governing the epithelial to mesenchymal transition (EMT) that facilitate metastasis. This review also discusses the role of cancer stem cells (CSCs), tumor-derived exosomes, and CTs in promoting BC metastasis. Furthermore, the review emphasizes major signaling pathways that mediate metastasis in BC. Finally, the interplay among CSCs, exosomes, and CTCs in mediating metastasis have been highlighted. Therefore, understanding the molecular cues that mediate the association of CSCs, exosomes, and CTCs in TME helps to optimize systemic therapy to target metastatic BC. 相似文献
52.
Derek K. Chu Romina Brignardello-Petersen Gordon H. Guyatt Cristian Ricci Jon Genuneit 《Pediatric allergy and immunology》2022,33(1):e13609
Network meta-analyses (NMAs) simultaneously estimate the effects of multiple possible treatment options for a given clinical presentation. For allergists to benefit optimally from NMAs, they must understand the process and be able to interpret the results. Through a worked example published in Pediatric Allergy and Immunology, we summarize how to identify credible NMAs and interpret them with a focus on recent innovations in the GRADE approach (Grading of Recommendations Assessment, Development, and Evaluation). NMAs build on traditional systematic reviews and meta-analyses that consider only direct paired comparisons by including indirect evidence, thus allowing the simultaneous assessment of the relative effect of all pairs of competing alternatives. Our framework informs clinicians of how to identify credible NMAs and address the certainty of the evidence. Trustworthy NMAs fill a critical gap in providing key inferences using direct and indirect evidence to inform clinical decision making when faced with more than two competing courses of treatment options. This document will help allergists to identify trustworthy NMAs to enhance patient care. 相似文献
53.
54.
《Mayo Clinic proceedings. Mayo Clinic》2022,97(7):1282-1293
ObjectiveTo assess the association between adherence to a Mediterranean lifestyle and changes in pain, and its characteristics over time in older adults.Patients and MethodsWe analyzed data from 864 and 862 community-dwelling individuals aged 65+ years from the Study on Cardiovascular Health, Nutrition and Frailty in Older Adults in Spain (Seniors-ENRICA) Seniors-ENRICA-1 (2008–2010 to 2012) and Seniors-ENRICA-2 (2015–2017 to 2019) cohorts, with a median follow-up of 2.8 and 2.4 years, respectively. Adherence to a Mediterranean lifestyle was assessed at baseline with the 27-item Mediterranean lifestyle (MEDLIFE) index. Pain changes over time were calculated with a pain scale that assessed the frequency, severity, and the number of pain locations both at baseline and follow-up. Multivariable-adjusted relative risk ratios (RRRs) were obtained using multinomial logistic regression.ResultsIn the pooled cohorts, after a median follow-up of 2.6 years, pain worsened for 697 participants, improved for 734, and did not change for 295. Compared with the lowest category of MEDLIFE adherence, those in the highest category showed an RRR of improvement vs worsening of overall pain of 1.85 (95% CI, 1.28 to 2.67; P-trend<.001). MEDLIFE adherence was also linked to improvement in pain frequency (RRR, 1.98; 95% CI, 1.31 to 3.01; P-trend=.001), pain severity (RRR, 2.00; 95% CI, 1.33 to 3.00; P-trend=.001), and a reduction in the number of pain locations (RRR, 1.68; 95% CI, 1.13 to 2.50; P-trend=.004). Limitations of this study are the use of self-reported lifestyle data.ConclusionA Mediterranean lifestyle was associated with improvement of pain characteristics in older adults. Experimental studies should assess the efficacy of an integral lifestyle approach for the management of pain in older adults. 相似文献
55.
56.
57.
《Value in health》2022,25(2):178-184
ObjectivesThe ALIC4E trial has shown that oseltamivir reduces recovery time while increasing the risk of nausea. This secondary analysis of the ALIC4E trial aimed to determine the gain in quality-adjusted life-years (QALYs) associated with adding oseltamivir to usual primary care in patients presenting with influenza-like illness (ILI).MethodsPatients with ILI were recruited during the influenza season (2015-2018) in 15 European countries. Patients were assigned to usual care with or without oseltamivir through stratified randomization (age, severity, comorbidities, and symptom onset). Patients’ health status was valued with the EQ-5D and visual analog scale (VAS) for up to 28 days. Average EQ-5D and VAS scores over time were estimated for both treatment groups using one-inflated beta regression in children (<13 years old) and adults (≥13 years old). QALY gain was calculated as the difference between the groups. Sensitivity analysis considered the value set to convert EQ-5D answers to summary scores and the follow-up period.ResultsIn adults, oseltamivir gained 0.0006 (95% confidence interval 0.0002-0.0010) QALYs, whereas no statistically significant gain was found in children (14-day follow-up, EQ-5D). QALY gains were statistically significant in patients aged ≥65 years, patients without relevant comorbidities, or patients experiencing symptoms for ≤48 hours. Using VAS and accounting for 28-day follow-up resulted in higher QALY gain.ConclusionsQALY gain owing to oseltamivir is limited compared with other diseases, and its clinical meaningfulness remains to be determined. Further analysis is needed to evaluate whether QALY gain and its impact on ILI treatment cost render oseltamivir cost-effective. 相似文献
58.
59.
60.